miR-107 inhibited malignant biological behavior of non-small cell lung cancer cells by regulating the STK33/ERK signaling pathway in vivo and vitro
Xueqiang Wei(Kunming Medical University), Yunchao Huang(Zhejiang Chinese Medical University)
Cited by 21
Related Papers
Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial
|The Lancet Respiratory Medicine|2021|183
Household air pollution and epigenetic aging in Xuanwei, China
|Environment International|2023|26
The influences of TGF-β1 upon the human adenocarcinoma cell of lung A549 and cellular immunity
|Annals of Translational Medicine|2020|8